Discounted Cash Flow (DCF) Analysis Levered

PetMed Express, Inc. (PETS)

$15.75

+0.30 (+1.94%)
Financial Summary
Financial Statements
Quarter Financials
Chart
Financial Ratios
Profile
Historical Data
DCFDCF Levered
All numbers are in Millions, Currency in USD

Free Cash Flow

Year
A/P
2020
Actual
2021
Actual
2022
Actual
2023
Actual
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Revenue 284.13309.21273.42256.86249.32242.01234.90228.01221.32
Revenue (%)
Operating Cash Flow 38.8440.0718.5027.8027.5626.7525.9725.2124.47
Operating Cash Flow (%)
Capital Expenditure -2.31-2.43-1.75-5.26-2.67-2.59-2.52-2.44-2.37
Capital Expenditure (%)
Free Cash Flow 36.5337.6416.7522.5424.8924.1623.4522.7622.10

Weighted Average Cost Of Capital

Share price $ 15.75
Beta 0.644
Diluted Shares Outstanding 20.34
Cost of Debt
Tax Rate 85.29
After-tax Cost of Debt 0.74%
Risk-Free Rate
Market Risk Premium
Cost of Equity 6.734
Total Debt -
Total Equity 320.34
Total Capital -
Debt Weighting -
Equity Weighting -
Wacc

Build Up Free Cash Flow

Year
A/P
2020
Actual
2021
Actual
2022
Actual
2023
Actual
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Revenue 284.13309.21273.42256.86249.32242.01234.90228.01221.32
Operating Cash Flow 38.8440.0718.5027.8027.5626.7525.9725.2124.47
Capital Expenditure -2.31-2.43-1.75-5.26-2.67-2.59-2.52-2.44-2.37
Free Cash Flow 36.5337.6416.7522.5424.8924.1623.4522.7622.10
WACC
PV LFCF 24.89----
SUM PV LFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) -
Free cash flow (t + 1) 22.54
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -104.09
Equity Value -
Shares Outstanding 20.34
Equity Value Per Share -